Coronavirus Vaccine Maker German Biotech Firm’s Stock Almost Triple On Debut
While pharma companies and other institutions all around the world are in the race of developing the bets vaccine for the novel coronavirus, its effect is being felt on the Wall Street also. After getting listed on Friday, the stock of the German firm CureVac, a biotech firm that is backed by the Bill &…









